Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Kallioniemi

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Cancer Research|November 5, 2002
Impact of DNA amplification on gene expression patterns in breast cancerElizabeth Hyman, Päivikki Kauraniemi, Sampsa Hautaniemi, et al.
Cancer Research|May 1, 2002
Targets of gene amplification and overexpression at 17q in gastric cancerAsta Varis, Maija Wolf, Outi Monni, et al.
International Journal of Cancer|March 31, 2019
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patientsAnna Nurmi, Taru A Muranen, Liisa M Pelttari, et al.
Science Translational Medicine|February 24, 2012
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functionsSzilvia Solyom, Bernadette Aressy, Katri Pylkäs, et al.
Plos One|November 17, 2011
Characterization of non-specific cytotoxic cell receptor protein 1: a new member of the lectin-type subfamily of F-box proteinsHeini Kallio, Martti Tolvanen, Janne Jänis, et al.
Journal of Medical Genetics|June 2, 2012
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancerLiisa M Pelttari, Johanna Kiiski, Riikka Nurminen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim, Anne Kallioniemi, Bodil Bjerkhagen, et al.
Journal of Translational Medicine|March 19, 2008
Hypermethylated MAL gene - a silent marker of early colon tumorigenesisGuro E Lind, Terje Ahlquist, Matthias Kolberg, et al.
Nature Genetics|May 22, 2002
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityDmitry V Bulavin, Oleg N Demidov, Shin'ichi Saito, et al.
Scientific Reports|November 30, 2023
NTHL1 is a recessive cancer susceptibility geneAnna K Nurmi, Liisa M Pelttari, Johanna I Kiiski, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Cancer Research|November 5, 2002
Impact of DNA amplification on gene expression patterns in breast cancerElizabeth Hyman, Päivikki Kauraniemi, Sampsa Hautaniemi, et al.
Cancer Research|May 1, 2002
Targets of gene amplification and overexpression at 17q in gastric cancerAsta Varis, Maija Wolf, Outi Monni, et al.
International Journal of Cancer|March 31, 2019
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patientsAnna Nurmi, Taru A Muranen, Liisa M Pelttari, et al.
Science Translational Medicine|February 24, 2012
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functionsSzilvia Solyom, Bernadette Aressy, Katri Pylkäs, et al.
Plos One|November 17, 2011
Characterization of non-specific cytotoxic cell receptor protein 1: a new member of the lectin-type subfamily of F-box proteinsHeini Kallio, Martti Tolvanen, Janne Jänis, et al.
Journal of Medical Genetics|June 2, 2012
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancerLiisa M Pelttari, Johanna Kiiski, Riikka Nurminen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim, Anne Kallioniemi, Bodil Bjerkhagen, et al.
Journal of Translational Medicine|March 19, 2008
Hypermethylated MAL gene - a silent marker of early colon tumorigenesisGuro E Lind, Terje Ahlquist, Matthias Kolberg, et al.
Nature Genetics|May 22, 2002
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityDmitry V Bulavin, Oleg N Demidov, Shin'ichi Saito, et al.
Scientific Reports|November 30, 2023
NTHL1 is a recessive cancer susceptibility geneAnna K Nurmi, Liisa M Pelttari, Johanna I Kiiski, et al.
Pageof 9